Report

Pharmacy Outlook 2026

Powered by Accelerate Pharmacy Solutions, the Pharmacy Outlook 2026 report draws on proprietary survey data from more than 100 health system pharmacy leaders navigating payer restrictions, specialty leakage, infusion expansion, and evolving regulatory pressures.

A few findings from this year's research:

  • Half of specialty patients are filling prescriptions externally—even at programs with mature operations
  • The average time-to-therapy is 5.7 days, nearly double the 3-day target for optimized programs
  • Two-thirds of health systems have yet to invest in home infusion, despite a rapidly growing market

Fill out the form to gain full access to the report

About Accelerate Pharmacy Solutions 

Accelerate Pharmacy Solutions partners with health systems to optimize pharmacy performance across specialty, 340B, infusion, procurement, and supply chain. The Pharmacy Outlook is part of our commitment to advancing the industry through data-driven insights.

Related resources

Article

Cell and gene therapy program implementation: Lessons from leading health systems
Learn more

Webinar

2026 Leadership Insights Series
Learn more

Article

Cell and gene therapy integration: health system strategies for advancing patient care
Learn more

Ready to transform your pharmacy and supply chain operations?

Connect with our team to explore how Accelerate Pharmacy Solutions can address your specific challenges. We'll schedule a consultation to understand your goals and demonstrate how our integrated approach delivers measurable results.